Showing results (61-70 of 140) with videos related to
Sort By:
Pageof 14
Acta Biochimica Polonica|August 28, 2012
Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirinElżbieta Jabłonowska, Anna Piekarska, Ewa Koślińska-Berkan, et al.Przeglad Epidemiologiczny|September 13, 2006
[Brain abscess: analysis of prevalence and clinical course]Kamila Wójcik, Eliza Dalecka-Sztwiertnia, Anna Piekarska, et al.Przeglad Epidemiologiczny|February 19, 2017
Epidemiology of hepatitis C virus infections in Łódzkie voivodeshipAleksandra Berkan-Kawińska, Anna Piekarska, Ewa Koślińska-Berkan, et al.Klinika Oczna|January 19, 2006
[Ophthalmological tests value in detection of the optic neuropathy associated with pituitary tumours]Anna Piekarska, Wojciech Lubiński, Olgierd Palacz, et al.Klinika Oczna|December 31, 2008
[Value of mfVEP test in pituitary tumors diagnosis]Anna Piekarska, Wojciech Lubiński, Wojciech Gosławski, et al.Molecules (Basel, Switzerland)|November 13, 2021
Effectiveness of the Influence of Selected Essential Oils on the Growth of Parasitic Fusarium Isolated from Wheat Kernels from Central EuropeTeresa Krzyśko-Łupicka, Sławomir Sokół, Monika Sporek, et al.Clinical and Experimental Hepatology|September 11, 2019
Prevalence of hepatitis C virus infection in patients hospitalised for ischemic heart disease versus controls - PRO-CARDIO-C studyAnna Piekarska, Aleksandra Mamzer-Dachnowska, Jarosław D Kasprzak, et al.Przeglad Gastroenterologiczny|March 25, 2017
Diagnostic value of optimised real-time sonoelastography in the assessment of liver fibrosis in chronic hepatitis B and CKatarzyna Kalita, Krzysztof Filipczak, Małgorzata Bieńkiewicz, et al.International Journal of Molecular Medicine|July 14, 2011
Coordinated increase of miRNA-155 and miRNA-196b expression correlates with the detection of the antigenomic strand of hepatitis C virus in peripheral blood mononuclear cellsMartyna Grek, Anna Piekarska, Jacek Bartkowiak, et al.Clinical and Experimental Hepatology|September 1, 2017
Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life populationAnna Piekarska, Ewa Koślińska-Berkan, Kamila Wójcik, et al.Pageof 14